Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiles of HiDEP after treatment with Fluoro-SAHA or M344

ABSTRACT: Gene expression profiles of HiDEP after treatment with Fluoro-SAHA or M344

PROVIDER: PRJNA577888 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression profiles of HiDEP after treatment with Fluoro-SAHA or M344

Project description:Total RNA was extrected from HiDEP-1 (Immortalized erythroid cell line derived from human induced pluripotent stem cells; PMID: 23533656) cultured with HDAC inhibitors, Fluoro-SAHA (FS) or M344 or Valproic acid (VPA), for 24 hours using Rneasy Mini Kit (QIAGEN) by following the manufacture's protocol. After the quality/quantity determination, RNA was subjected to expression analyses using Affymetrix GeneChip® Array / Human Gene 2.0 ST Array

2021-05-01 | GSE138958 | GEO

Gene expression + ATAC profiling of trisomic hippocampal neurons upon SAHA treatment [ATAC-seq]

Project description:Gene expression + ATAC profiling of trisomic hippocampal neurons upon SAHA treatment [ATAC-seq]

| PRJNA1455549 | ENA

Gene expression + ATAC profiling of trisomic hippocampal neurons upon SAHA treatment [RNA-seq]

Project description:Gene expression + ATAC profiling of trisomic hippocampal neurons upon SAHA treatment [RNA-seq]

| PRJNA1455548 | ENA

Expression data in MDA-MB-231 breast cancer cell lines with Histone deacetylase SAHA treatment

Project description:Analysis of gene expression change after 8hr's treatment with 5μM SAHA, which is a histone deacetylase inhibitor, in MDA-MB-231 cell lines.

2016-01-26 | GSE77200 | GEO

Global mRNA expression profiling of murine primary PDAC cells following JQ1 or SAHA monotherapy as well as JQ1-SAHA combination therapy

Project description:Global mRNA expression profiles of murine primary PDAC cells following JQ1 or SAHA monotherapy as well as JQ1-SAHA combination therapy were collected using Affymetix mouse whole genome array (Mouse Genome 430A 2.0 Array) . Primary PDAC cells isolated from Ptf1aCre/+;Kras+/LSL-G12D;p53lox/lox (Kras;p53) mice were treated either with JQ1 (100 nM) or SAHA (2000 nM) or vehicle 10% (2-Hydroxypropyl)-β-cyclodextrin (Sigma-Aldrich) or as combination therapy with the indicated dosage for monotherapy. Total RNA isolation was performed after 6 hours of treatment.

2015-09-20 | GSE64836 | GEO

Development of gene expression signatures of B7-H3 CAR-T cells for treatment of SAHA

Project description:Development of gene expression signatures of B7-H3 CAR-T cells for treatment of SAHA

| PRJNA558693 | ENA

Global mRNA expression profiling of murine primary PDAC cells following JQ1 or SAHA monotherapy as well as JQ1-SAHA combination therapy

2015-09-20 | E-GEOD-64836 | biostudies-arrayexpress

HDAC inhibitor SAHA reverses inflammatory gene expression in diabetic endothelial cells

Project description:While histone deacetylase (HDAC) inhibitors are thought to regulate gene expression by post-translational modification of histone as well as non-histone proteins. While histone hyperacetylation has long been considered the paradigmatic mechanism of action, recent genome-wide profiles indicate more complex interactions with the epigenome. In particular, HDAC inhibitors also induce histone deacetylation at the promoters of highly active genes, resulting in gene suppression. This was linked to the loss of histone acetyltransferase (HAT) binding. To illustrate pre-clinical utility of the HDAC inhibitor SAHA as a therapeutic, we show reversal of diabetes-associated EP300 target genes in diabetic HAECs of primary origin. These results were confirmed using SAHA, C646 (EP300/CREBBP inhibitor) or EP300 siRNA. These findings suggest the inhibition of gene expression by SAHA is mediated by EP300 function and provide a rationale for clinical trials of safety and efficacy in patients with diabetes.

2017-12-06 | GSE77108 | GEO

Genome wide analysis of SAHA (vorinostat) treatment in primary mouse cortical neurons upon miR-203 overexpression

Project description:Purpose: The goal of this study was to assess gene expression changes upon SAHA treatment in cells overexpressing miR-203.

2018-08-28 | GSE115206 | GEO

SAHA, VPA and JQ1 treatment in ISOS-1

Project description:SAHA, VPA and JQ1 treatment in ISOS-1

| PRJNA823003 | ENA